Sterling Investment Counsel’s iShares Biotechnology ETF IBB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-1,521
| Closed | -$201K | – | 175 |
|
|
2024
Q4 | $201K | Hold |
1,521
| – | – | 0.13% | 126 |
|
|
2024
Q3 | $221K | Hold |
1,521
| – | – | 0.08% | 159 |
|
|
2024
Q2 | $209K | Sell |
1,521
-94
| -6% | -$12.9K | 0.08% | 155 |
|
|
2024
Q1 | $222K | Sell |
1,615
-156
| -9% | -$21.4K | 0.1% | 153 |
|
|
2023
Q4 | $241K | Sell |
1,771
-23
| -1% | -$3.12K | 0.12% | 130 |
|
|
2023
Q3 | $219K | Hold |
1,794
| – | – | 0.13% | 136 |
|
|
2023
Q2 | $228K | Buy |
1,794
+213
| +13% | +$27K | 0.12% | 135 |
|
|
2023
Q1 | $204K | Hold |
1,581
| – | – | 0.12% | 147 |
|
|
2022
Q4 | $208K | Buy |
+1,581
| New | +$208K | 0.13% | 145 |
|
|
2022
Q2 | – | Sell |
-1,685
| Closed | -$220K | – | 151 |
|
|
2022
Q1 | $220K | Sell |
1,685
-116
| -6% | -$15.1K | 0.15% | 137 |
|
|
2021
Q4 | $275K | Buy |
+1,801
| New | +$275K | 0.19% | 114 |
|